SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 298.89 |
| Enterprise Value ($M) | 243.25 |
| Book Value ($M) | 244.02 |
| Book Value / Share | 4.25 |
| Price / Book | 1.22 |
| NCAV ($M) | 59.08 |
| NCAV / Share | 1.03 |
| Price / NCAV | 5.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.03 |
| Return on Assets (ROA) | 0.03 |
| Return on Equity (ROE) | 0.05 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.64 |
| Current Ratio | 3.43 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 169.96 |
| Assets | 354.91 |
| Liabilities | 110.89 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 142.52 |
| Operating Income | 10.06 |
| Net Income | 8.28 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 4.32 |
| Cash from Investing | -5.84 |
| Cash from Financing | 22.68 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Gov Financial Holdings Ltd. | 6.15 | -1.76 | |
| 13G/A | Phoenix Holdings Ltd. | 7.51 | 0.00 | |
| 13D/A | Davidi Ishay | 38.42 | 133.63 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 952 | 5,296 | 17.98 | |
| 3,668 | 2,820 | 130.07 | |
| 1,782 | 4,919 | 36.23 | |
| 391 | 520 | 75.19 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IRWD – Ironwood Pharmaceuticals, Inc. | ITCI – Intra-Cellular Therapies, Inc. |
| JAZZ – Jazz Pharmaceuticals plc | KNSA – Kiniksa Pharmaceuticals, Ltd. |
| KPTI – Karyopharm Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io